Compare Citra Nusantara Gemilang Tbk. (CGAS) vs Hetzer Medical Indonesia Tbk. (MEDS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Citra Nusantara Gemilang Tbk. vs Hetzer Medical Indonesia Tbk. — how do they compare? Citra Nusantara Gemilang Tbk. trades at Rp153 (market cap 272.81B, 2.76M 24h volume), while Hetzer Medical Indonesia Tbk. trades at Rp83 (market cap 126.56B, 285.35M 24h volume). The key difference: Citra Nusantara Gemilang Tbk. is far larger — about 2.2× Hetzer Medical Indonesia Tbk.'s market cap, and Hetzer Medical Indonesia Tbk. is more actively traded (285.35M versus 2.76M). Which is the better fit depends on your goals.
| CGAS | MEDS | |
|---|---|---|
Market Cap | 272.81B | 126.56B |
Volume | 2.76M | 285.35M |
Lot | 27.63K | 2.85M |
Turnover | 422.4M | 24.59B |
Average Price | 152.91 | 86.17 |
Value | 422.4M | 24.59B |
Indicative Equilibrium Price | 154 | 84 |
Indicative Equilibrium Volume | 94.2K | 22.76K |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Citra Nusantara Gemilang Tbk.
PT Citra Nusantara Gemilang Tbk (the “Company”), was established based on Notarial Deed No. 22, dated December 21, 2005 of Edi Priyono, S.H.. The Company's parent entity is PT Petro Asia Energy
Read more on CGAS →About Hetzer Medical Indonesia Tbk.
PT Hetzer Medical Indonesia Tbk (the Company) was established based on Notarial Deed of Cahya Suryana, S.H., Notary in Bandung, No. 12 dated December 31, 2010.
Read more on MEDS →
